Protecting Americans’ Social Security Data Act

American Innovation and R&D Competitiveness Act of 2025

NEDD Act Nuclear Ecosystem Drone Defense Act

COMPLETE Care Act Connecting Our Medical Providers with Links to Expand Tailored and Effective Care

SSI Savings Penalty Elimination Act

Building Child Care for a Better Future Act

Invest to Protect Act of 2025

American Family Act

Tax Cut for Workers Act of 2025

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Southern Nevada Economic Development and Conservation Act

SLOT Act of 2025 Shifting Limits on Thresholds Act of 2025

Puppy Protection Act of 2025

Capping Prescription Costs Act of 2025

Lower Drug Costs for Families Act This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance. Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties. The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).